Evidence map›Paper›PMID 39543123›Full record

ArticleCell death & disease2024

Ally or traitor: the dual role of p62 in caspase-2 regulation.

Pavel I Volik, Alexey V Zamaraev, Aleksandra Y Egorshina, Nikolay V Pervushin, Anastasia A Kapusta, Pyotr A Tyurin-Kuzmin, Anastasia V Lipatova, Thilo Kaehne, Inna N Lavrik, Boris Zhivotovsky and 1 more

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pavel I VolikEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia.
Alexey V ZamaraevEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia.ORCID 0000-0003-0509-6323
Aleksandra Y EgorshinaEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia.ORCID 0000-0001-7818-1161
Nikolay V PervushinEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia.
Anastasia A KapustaFaculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.
Pyotr A Tyurin-KuzminFaculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.
Anastasia V LipatovaEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia.
Thilo KaehneTranslational Inflammation Research, Medical Faculty, Center of Dynamic Systems (CDS), Otto von Guericke University, Magdeburg, Germany.
Inna N LavrikTranslational Inflammation Research, Medical Faculty, Center of Dynamic Systems (CDS), Otto von Guericke University, Magdeburg, Germany.
Boris ZhivotovskyEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia. boris.zhivotovsky@ki.se.ORCID 0000-0002-2238-3482
Gelina S KopeinaEngelhardt Institute of Molecular Biology, RAS, Moscow, Russia. lirroster@gmail.com.ORCID 0000-0002-7143-6923

Funding

Cancerfonden (Swedish Cancer Society) 222013Radiumhemmets Forskningsfonder (Cancer Research Foundations of Radiumhemmet) 181301Russian Science Foundation (RSF) 23-74-30006
6 · The paper itself

Abstract

Caspase-2 is a unique and conserved cysteine protease that is involved in several cellular processes, including different forms of cell death, maintenance of genomic stability, and the response to reactive oxygen species. Despite advances in caspase-2 research in recent years, the mechanisms underlying its activation remain largely unclear. Although caspase-2 is activated in the PIDDosome complex, its processing could occur even in the absence of PIDD1 and/or RAIDD, suggesting the existence of an alternative platform for caspase-2 activation. Here, we show that caspase-2 undergoes ubiquitination and interacts with scaffolding protein p62/sequestosome-1 (SQSTM1) under normal conditions and in response to DNA damage. p62 promotes proteasomal but not autophagic caspase-2 degradation as well as its dimerization and activation that triggers the caspase cascade and, subsequently, cell death. Inhibition of p62 expression attenuates cisplatin-induced caspase-2 processing and apoptosis. Notably, the ZZ domain of p62 is critical for caspase-2 binding, whereas the UBA domain is seemingly required to stabilize the p62-caspase-2 complex. Thus, we have uncovered the dual role of p62 in regulating caspase-2 activity: it can foster the degradation of caspase-2 in the proteasome or facilitate its activation by acting as a scaffold platform.

Indexed as

ApoptosisCaspase 2Sequestosome-1 ProteinUbiquitinationCisplatinCysteine EndopeptidasesDNA DamageHEK293 CellsHeLa CellsHumansProteasome Endopeptidase ComplexProtein BindingProteolysisCASP2 protein, humanCaspase 2CisplatinCysteine EndopeptidasesProteasome Endopeptidase ComplexSequestosome-1 ProteinSQSTM1 protein, human

Identifiers

PMID39543123
PMCPMC11564777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.